Not for distribution to U.S. Newswire Services or for dissemination in the United States.
Indiva Ships its White Russian Pre-rolls to the Ontario Cannabis Store
LONDON, ON – May 23, 2019: Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (US:NDVAF) is pleased to announce the release of its new White Russian pre-rolls to the Ontario consumer market through the OCS.ca website and in licensed cannabis stores in Ontario.
The White Russian strain has been a staple of the cannabis community for decades and is a combination of two legendary cultivars, White Widow and AK-47. White Russian won “Best Overall” at the High Times Cannabis Cup in 1996, and at one time was considered the strongest strain in the world.
INDIVA™ White Russian pre-rolls are carefully hand-crafted from ground flower and hand-weighed with precision in our London, Ontario facility. The first shipment to the Ontario Cannabis Store (OCS) took place on May 22nd, just in time for summer.
“This Indica-dominant hybrid grown by Indiva in our facility in London will provide a smooth and mellow experience to both the enthusiast and the newcomer,” said Niel Marotta, President and CEO of Indiva. “The pre-rolls will be available in two pre-roll packs totalling one-gram of premium INDIVA™ cannabis.”
Niel Marotta, CEO, INDIVA
Email: [email protected]
Steve Low, Investor Relations
Email: [email protected]
Indiva is a Licensed Producer of medical grade cannabis. Our aim is to bring our family of global cannabis brands to Canadians and cannabis enthusiasts around the world. As marijuana laws liberalize globally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint- ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.
DISCLAIMER & READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward- looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary regulatory and other third parties approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.